Seroprevalence of Hepatitis B Surface Antigen, Anti-Hepatitis B Surface and Anti-Hepatitis C Virus Among Pregnant Women Residing in Şırnak Province
Journal Title: Viral Hepatitis Journal - Year 2018, Vol 24, Issue 1
Abstract
Objectives: The purpose of the study was to detect the rate of hepatitis B surface antigen (HBsAg), anti-HBs and anti-hepatitis C virus (HCV) seropositivity among pregnant women residing in the city of Şırnak. Materials and Methods: Results of serological tests for HBsAg, anti-HBs and anti-HCV in 2214 pregnant women, who were admitted to the Gynecology and Obstetrics Clinics and Emergency Departments at Şırnak State Hospital and Cizre State Hospital between the dates of April 1, and October 1, 2017, were retrospectively evaluated. Results: A total of 2214 pregnant women were included in this study. It was determined that the rate of seropositivity for HBsAg, anti-HBs and anti-HCV was 1%, 27.8%, and 0.21%, respectively. It was found that anti-HBs seropositivity rate among pregnant women younger than 19 years was 54.5%, which was higher than in those aged 19 years or older. Conclusion: Anti-HCV positivity rate detected in pregnant women who resided in Şırnak was found to be similar to the results reported in other studies conducted in our country, however, HBsAg positivity rate was found to be lower when compared with the results of other studies. A significant increase was detected in anti-HBs seropositivity rate in Şırnak since hepatitis B vaccine was included in the national immunization schedule.
Authors and Affiliations
Meyha ŞAHİN, Meltem ZENCİR, Alper Akın GÖZÜBÜYÜK, Bedri Aras PEKTAŞ
Keywords
Related Articles
- EP ID EP364612
- DOI 10.4274/vhd.0010
- Views 44
- Downloads 0
Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
Objective: Chronic hepatitis C (CHC) virus infection is one of the leading causes of chronic liver disease in all over the world. The prevalence of CHC is almost 0.5-1% in Turkey. Until recently, pegylated-interferon (PE...
A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis
Hepatomegaly and steatosis are rare but potentially fatal side-effects of nucleoside analogues. Here, we present the case of development of hepatomegaly and steatosis in a 53-year-old male who had been treated with entec...
Are Liver Transaminases and Hepatitis C Virus-RNA Viral Loads Reliable Markers for Estimating Liver Fibrosis in Patients Recently Diagnosed with Hepatitis C? Evaluation of the Data of Ninety-five Young and Middle-aged Males in a Genotype-1b Prevalent Country
Objectives: Although liver biopsy is an invasive test, it is still considered as the gold standard method for determining the severity of liver diseases. Materials and Methods: A total of 95 young and middle-aged male pa...
Is There an Association Between Hepatitis B and Atherosclerosis?
Objectives: Although hepatitis B infection can cause chronic disease, its association with atherosclerosis is a matter of debate. Retinopathy is an early marker for microvascular abnormalities of retinal circulation and...
Should Hepatitis C Virus Antibody Be Used for Screening Purposes?
Objectives: In this study, hepatitis C virus (HCV) RNA results were retrospectively investigated in patients with reactive HCV antibodies. Materials and Methods: HCV antibody test was performed ELISA method. Enzyme link...